Contact this trialFirst, we need to learn more about you.
Immunosuppressant
Mycophenolate Mofetil for Systemic Sclerosis with Interstitial Lung Disease
Recruiting0 awardsPhase 2
Quebec City, Quebec
This trial will study the effects of a drug on people with mild lung involvement from systemic sclerosis. Participants will get either drug or placebo over 96 weeks at 3 centers.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service